Experimental drug targets specific protein in advanced lung cancer

NCT ID NCT04189614

Ongoing Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing whether a new drug called cofetuzumab pelidotin is safe and effective for people with recurrent non-small cell lung cancer that has a specific protein called PTK7. The trial involves 65 participants whose cancer has returned after previous treatments. Researchers are measuring how well the drug shrinks tumors and how long patients live without their cancer getting worse.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Asan Medical Center /ID# 222280

Seoul, Seoul Teugbyeolsi, 05505, South Korea
CHA Bundang Medical Center /ID# 232514

Seongnam, Gyeonggido, 13496, South Korea
Duplicate_Stanford University School of Med /ID# 213450

Stanford, California, 94305-2200, United States
Highlands Oncology Group, PA /ID# 215383

Springdale, Arkansas, 72762, United States
Hospital Universitario Fundacion Jimenez Diaz /ID# 215110

Madrid, 28040, Spain
Hospital Universitario HM Sanchinarro /ID# 215102

Madrid, 28050, Spain
Hospital Universitario Vall de Hebron /ID# 215729

Barcelona, 08035, Spain
Linkou Chang Gung Memorial Hospital /ID# 222603

Taoyuan, 333, Taiwan
Moffitt Cancer Center /ID# 215101

Tampa, Florida, 33612-9416, United States
National Cancer Center Hospital /ID# 218536

Chuo-ku, Tokyo, 104-0045, Japan
National Cancer Center Hospital East /ID# 218537

Kashiwa-shi, Chiba, 277-8577, Japan
National Cheng Kung University Hospital /ID# 222602

Tainan, 704, Taiwan
Oncology Consultants /ID# 215932

Houston, Texas, 77030-3306, United States
Rabin Medical Center. /ID# 217537

Petah Tikva, 4941492, Israel
Rambam Health Care Campus /ID# 217536

Haifa, 3109601, Israel
Samsung Medical Center /ID# 222906

Seoul, Seoul Teugbyeolsi, 06351, South Korea
Sylvester Comprehensive Cancer Center /ID# 216433

Miami, Florida, 33136-1002, United States
Tennessee Oncology, PLLC /ID# 215326

Nashville, Tennessee, 37203, United States
The Chaim Sheba Medical Center /ID# 217538

Ramat Gan, Tel Aviv, 5265601, Israel
The Ohio State University /ID# 211088

Columbus, Ohio, 43210, United States
Univ of Colorado Cancer Center /ID# 215295

Aurora, Colorado, 80045, United States
University of Alabama at Birmingham - Main /ID# 213605

Birmingham, Alabama, 35233, United States
University of Texas MD Anderson Cancer Center /ID# 215876

Houston, Texas, 77030, United States
Virginia Cancer Specialists - Fairfax /ID# 216427

Fairfax, Virginia, 22031, United States
Washington University-School of Medicine /ID# 213453

St Louis, Missouri, 63110, United States
Yonsei University Health System Severance Hospital /ID# 222281

Seoul, 03722, South Korea

Conditions

Explore the condition pages connected to this study.

CANCER NON-SMALL CELL LUNG CANCER (NSCLC)